Uncategorized
SkyVision enters age of LipiFlow
Nothing makes me crankier than seeing a promising medical technology or treatment held hostage by a bad business plan. As an aside, nothing I write produces more agita in my editors than when I propose to vent my spleen on topics such as this. I find it even more distressing when cool stuff is marketed primarily on the financial benefits a test or treatment will bring to the practice that adopts the new technology. This is especially depressing when the technology is not only cool in its own right, but (Read more...)